SERA names India as partner country for Blue Origin space flight

The U.S.-based Space Exploration and Research Agency (SERA) on Monday announced India as a partner country in its human spaceflight programme, which will see six citizen astronauts from across the world launched into space.

The programme, being executed in collaboration with Blue Origin, is meant for people from countries who have sent “few or no astronauts” to space, the agency said.

The selected citizens will undertake the 11-minute journey in New Shepard, Blue Origin’s reusable suborbital rocket, after undergoing training at its launch site in West Texas.

“We want to make space accessible for everyone and are happy to offer this unique opportunity to an Indian citizen who wants to experience the wonders of space travel,” SERA Co-Founder Joshua Skurla said.

People interested in the programme will have to pay $2.50 to cover verification checks and will have to meet certain physical requirements, SERA said.

The final candidate will be selected by the public through a public vote.

“This approach (of public voting) will ignite national conversations on space and foster international collaboration in space exploration,” SERA Co-Founder Sam Hutchison said.

India has achieved key milestones in the space sector in the last few months, the most significant of which was landing on the unexplored south pole of the moon – the first country to achieve the feat.

It also launched its first solar mission in September and is working with the Elon Musk-led SpaceX to launch a communications satellite.

Prime Minister Narendra Modi, who was sworn in for a rare third term last month, has been focusing on increased privatisation and commercialisation of the space sector, pushing for it to play a larger role on a world stage dominated by India and the U.S.

(Reuters)

RELATED ARTICLES

3 mins ago | Biocon gets European Commission nod

Biocon gets European Commission nod for breast cancer biosimilar Pebrilzo

Biopharmaceutical firm Biocon Ltd has received marketing authorisation from the European Commission (EC) for Pebrilzo, its pertuzumab biosimilar, to treat HER2-positive breast cancer across multiple disease stages in the European Union. Biocon's per...

13 mins ago | Crimean Bridge

Ukraine cripples Crimean road bridge in blow to Putin before meeting with Xi and Trump

Ukrainian drones and missiles destroyed the central road section of the bridge linking Russia and Crimea on Tuesday, inflicting a military and symbolic blow on President Vladimir Putin two days before he is due to meet the leaders of China and the US...

18 mins ago | Iranian attacks

Bahrain, Kuwait report Iranian attacks; US strikes Iranian missile site on Qeshm Island

Kuwait and Bahrain reported fresh Iranian attacks on Wednesday, amid renewed escalation in hostilities between the USA and Iran starting last week. Kuwait's Army posted on social media around midnight that their air defences were responding to hostil...